Cefdinir is an oral third-generation cephalosporin with enhanced Gram-positive and Gram-negative coverage, widely used for community-acquired respiratory, skin and ear infections, particularly in paediatric practice. Simson Pharma's Cefdinir reference standard and impurities support high-volume compendial testing for this commonly prescribed paediatric antibiotic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cefdinir Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.